• Profile
Close

Genetic polymorphisms in activating transcription factor 3 binding site and the prognosis of early-stage non-small cell lung cancer

Oncology Feb 27, 2021

Kang HG, Park JE, Lee SY, et al. - Researchers examined the link between variants in expression quantitative trait loci (eQTLs) within activating transcription factor 3 (ATF3) binding regions and the prognosis of non-small cell lung cancer (NSCLC) following surgery. Participants included 772 NSCLC cases managed with curative surgery. A total of 104 single nucleotide polymorphisms (SNPs) in eQTLs in the ATF3 binding regions were selected by utilizing a public database, and experts assessed the link of these SNPs with disease-free survival (DFS). Significantly worse DFS was observed in relation to HAX1 rs11265425T>G, while significantly better DFS was evident in relation to ME3 rs10400291C>A. In conclusions, functional polymorphisms in ATF3 binding sites, HAX1 rs11265425T>G and ME3 rs10400291C>A were identified to be related to the clinical results of patients in surgically resected NSCLC.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay